Sponsored • Adapting to the Coronavirus pandemic
Re-evaluating the value of generics to European hospitals
David Johnson, Global Director Commercial Excellence at ADVANZ PHARMA, explains the value of off-patent medicines to hospitals and healthcare systems, as the repercussions of the Covid-19 pandemic are still having a significant impact on resources.